Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity and Share-Based Compensation

v3.24.1.u1
Stockholders' Equity and Share-Based Compensation
3 Months Ended
Mar. 30, 2024
Stockholders' Equity and Share-Based Compensation  
Stockholders' Equity and Share-Based Compensation

Note 3 – Stockholders’ Equity and Share-Based Compensation

Options and Restricted Stock Units

The Company had the following common stock option activity during the thirteen weeks ended March 30, 2024:

Granted options to purchase 0 common shares.
Exercise of 0 options to purchase common shares.
Forfeiture of 4 options to purchase common shares.
Expiration of 0 options to purchase common shares.

The following table summarizes the Company’s restricted stock unit ("RSU") activity for the thirteen weeks ended March 30, 2024, and details regarding the awards outstanding and exercisable as of March 30, 2024 (in thousands):

Weighted Average

Grant Date

Aggregate

    

Shares

    

    

Fair Value

    

Intrinsic Value

Vested and expected to vest as of December 30, 2023

3,609

 

Awarded

2,058

 

Vested

(368)

 

Forfeited

(61)

 

Awards outstanding, March 30, 2024

5,238

 

$

6.59

 

$

8,485

Vested and expected to vest as of March 30, 2024

5,237

 

$

6.58

 

$

8,484

During the thirteen weeks ended March 30, 2024, 368 RSUs that vested were time-based and 0 were performance-based.

For the thirteen weeks ended March 30, 2024, we recorded compensation costs related to stock options and RSUs of $2,824. For the thirteen weeks ended April 1, 2023, we recorded compensation costs related to stock options and RSUs of $4,170. As of March 30, 2024, there was unrecognized compensation expense related to stock options and RSUs of $21,847 that will be expensed through March 2028.